Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003404
Status:
COMPLETED
Last Update Posted:
2019-01-22
First Post:
1999-11-01
Brief Title:
Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Dartmouth-Hitchcock Medical Center
Study Overview
Official Title:
A Prospective Study of Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors
Status:
COMPLETED
Status Verified Date:
2018-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
PURPOSE This phase II trial studied how well radiation therapy works after surgery in treating women with phyllodes tumor of the breast
RATIONALE Radiation therapy uses high-energy x-rays to damage tumor cells Radiation therapy following surgery may be effective in treating patients with phyllodes tumor of the breast
RATIONALE Radiation therapy uses high-energy x-rays to damage tumor cells Radiation therapy following surgery may be effective in treating patients with phyllodes tumor of the breast
Detailed Description:
OBJECTIVES
Determine the local recurrence rate in women with phyllodes tumors of the breast previously treated with local excision with negative margins and are now treated with adjuvant radiotherapy
Determine the survival rate in patients treated with this regimen
METHODS Within 12 weeks after prior local excision or breast reexcision patients underwent adjuvant radiotherapy 5 days a week for a total of 28 treatments Patients were then followed every 6 months for 10 years
Determine the local recurrence rate in women with phyllodes tumors of the breast previously treated with local excision with negative margins and are now treated with adjuvant radiotherapy
Determine the survival rate in patients treated with this regimen
METHODS Within 12 weeks after prior local excision or breast reexcision patients underwent adjuvant radiotherapy 5 days a week for a total of 28 treatments Patients were then followed every 6 months for 10 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P30CA023108 | NIH | None | None |
| DMS-9801 | None | None | None |
| DMS-12752 | None | None | None |
| NCI-V98-1442 | US NIH GrantContract | None | httpsreporternihgovquickSearchP30CA023108 |